Material Safety Data Sheet
DOT HCS Risk Phrases Protective Clothing
Class: Target organ effects.
Section I. Product Identification and Uses
Hyvisc庐 Injection (NADA #: 122-578)
Common/Trade name
Not applicable.
CI#
Sodium Hyaluronate
Synonyms TSCA inventory: No products were found.
DSL
Hyaluronate sodium. (Hyaluronic acid, sodium)
Chemical Name Mixture.
CAS #
One mL Hyvisc contains: 11 mg - hyaluronate sodium, 8.47 mg sodium
Chemical Formula MSDS ID#: P413015
Code
chloride, USP, steril water for injection, USP, qs
Not available.
Chemical Family 1.55 x 106 - 3.08 x 10 6 daltons
Molecular Weight
BOEHRINGER INGELHEIM VETMEDICA, INC.
Supplier Anika Therapeutis, Inc.
Manufacturer
2621 NORTH BELT HWY 236 West Cummings Park
ST. JOSEPH MO 64506-2002 Woburn, MA 01801
Treatment of joint dysfunction in equine.
Material Uses
Section 2. Hazardous Ingredients
Name Exposure Limits
CAS # % by Weight LC50/LD50
1) Chloroform 67-66-3 -0.001 TWA: 10 ppm ACGIH ORAL (LD50): Acute: 1336
TWA: 2 ppm OSHA mg/kg [Rat.]. VAPOR (LC50):
Acute: 9540 ppm 4 hour(s)
[Rat.]. DUST (LC50): Acute:
232910.6 mg/m3 4 hour(s)
[Rat.].
Section 3. Physical Data
Liquid.
Physical State and Not available.
Odor
Appearance
Not available.
Taste
5.5 - 7.5
pH (1% soln/water)
Clear
Color
Not available.
Odor threshold
Not available.
Volatility
Not available.
Melting/Sublimation point
Not available.
Boiling/Condensation point
1.005 - 1.020 at 25掳 C
Specific gravity
Not available.
Vapor Density
Not applicable.
Vapor pressure
Not available.
LogKow
Not available.
Ionicity (surface active
agent)
Not available.
Critical temperature
Not available.
Instability temperature
Stable for 2 years
Conditions of instability
Not available.
Dispersion properties
Not available.
Solubility
Continued on Next Page
Hyvisc庐 Injection (NADA #: Page Number: 2
122-578)
Section 4. First Aid Measures
Avoid contact with eyes.
Eye contact
In case of skin contact, rinse skin with water. Individuals prone to allergy to chicken or chicken derived products could
Skin contact
experience an adverse reaction.
No information available regarding inhalation. Seek immediate medical attention.
Slight inhalation
No information available regarding ingestion. Notify physician or Poison Control Center immediately.
Slight ingestion
Section 5. Fire and Explosion Data
Not explosive or a fire hazard, will burn if placed in flame.
The product is:
Not available.
Auto-ignition
temperature
These products are toxic fumes of: carbon monoxide carbon dioxide, Nitrogen oxides
Fire degradation
products
Not available.
Flash points
Not available.
Flammable limits
Not available.
Fire extinguishing
procedures
Not available.
Flammability
Non-explosive.
Risks of explosion
Section 6. Reactivity Data
Stability The product is stable for two years.
Hazardous Decomposition These products are halogenated compounds.
Products
Not available.
Degradability
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Products of
degradation
Not available
Non-corrosive in presence of glass.
Corrosivity
Not available
Reactivity
Continued on Next Page
Hyvisc庐 Injection (NADA #: Page Number: 3
122-578)
Section 7. Toxicological Properties
Eye Contact Ingestion: Inhalation: Skin contact.
Routes of entry
Not available.
TLV
No additional information.
Toxicity to animals
Chloroform: Suspect carcinogen
Chronic effects on
humans
Acute effects on humans Not available.
Section 8. Preventive Measures
Dissolve in a water solution and dispose of as a non-hazardous waste water.
Waste information
Not available.
Waste stream
Storage
Precautions
Use appropriate tools to put the spilled solid in a convenient waste disposal container.
Small spill and leak
No additional information
Large spill and leak
Goggles
Protective Clothing
Section 9. Classification
Not a DOT controlled material (United States).
DOT
Not applicable.
Not available.
Maritime
transportation
Class: Target organ effects.
HCS
Federal and State
Regulations
Not available
HMIS (U.S.A.) National Fire
* 1
Health Flammability
0
Protection Association
0
Flammability
1 0
Health Reactivity
(U.S.A.)
0
Reactivity
Specific Hazard
n
Personal Protection
Section 10. Protective Measures
Protective Clothing Splash goggles.
Engineering controls Good general ventilation should be sufficient to control airborne levels.
Continued on Next Page
Hyvisc庐 Injection (NADA #: Page Number: 4
122-578)
Section 11. Other Information
Not available.
References
Validated by Company on 08/05/2002. Verified by Company.
Printed 09/04/2002.
CALL 1(800) 821-7467
Emergency Medical: (816) 232-2525 or (800)530-5432
Chemtrec: (800)424-9300
To the best of our knowledge, the information contained herein is accurate. However, neither the above named supplier nor any of its
subsidiaries assumes any liability whatsoever for the accuracy or completeness of the information contained herein. Final
determination of suitability of any material is the sole responsibility of the user. All materials may present unknown hazards and should
be used with caution. Although certain hazards are described herein, we cannot guarantee that these are the only hazards that exist.
The information provided herein is offered by Boehringer Ingelheim Vetmedica, Inc. (鈥淏IV鈥?) in
good faith as accurate as of the date hereof, but without guarantee. This information includes
information which has been generated by other parties and provided to BIV, and which BIV has
not independently verified. The information provided herein relates only to the specific product
designated, and may not be valid where such product is used in combination with any other
materials or in any process. The information provided herein is offered solely for your
consideration, investigation and verification, and Boehringer Ingelheim Vetmedica, Inc. (鈥淏IV鈥?)
expressly disclaims all liability for reliance thereon. BIV EXPRESSLY DISCLAIMS ALL
WARRANTIES OF EVERY KIND AND NATURE (INCLUDING WARRANTIES OF
MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT
TO THE USE OR SUITABILITY OF THE PRODUCT. In addition, since the conditions of use
and suitability of the product for particular uses are beyond BIV鈥檚 control, ALL RISKS OF USE
OF THE PRODUCT ARE THEREFORE ASSUMED BY THE USER, AND BIV EXPRESSLY
DISCLAIMS ANY AND ALL LIABILITY AS TO ANY RESULTS OBTAINED OR
ARISING FROM ANY USE OF THE PRODUCT.
Use or re-transmission of the information contained herein in any other format than the format as
presented is strictly prohibited. Nothing herein shall be construed as a permission or
recommendation for the use of the product in a manner that might infringe an existing patent.
BIV neither represents nor warrants that the format, content or product formulas contained in this
document comply with the laws of any other country except the United States of America.
漏 Copyright 2001 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.
Disclaimer.doc
|